2018 annual financial data

Cartesian Therapeutics, Inc. 2018 Operating margin

Cartesian Therapeutics, Inc. 2018 operating margin with verified reported value…

Direct answer

Operating margin was -7,200.66%.

Operating income was -65,022,000 USD and net income was -65,336,000 USD.
Operating cash flow was -59,161,000 USD.

Get free Cartesian Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
903,000 USD
Operating income
-65,022,000 USD
Net income
-65,336,000 USD
Operating cash flow
-59,161,000 USD